Elaine K. Sorg is VP at AbbVie Inc. (ABBV). They have made 9 open-market trades across 1 company since 2021, most recently 2023-04-25.
CIK 0001832571
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABBV | 41,460 | $12.2M |
Shares reported on the most recent Form 4, priced at the 2023-04-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL · 10b5-1 | 2023-04-25 | 2023-04-27 | $165.00 | $1.0M | -0.8% | -7.8% | -4.1% |
| ABBV | SELL | 2023-04-17 | 2023-04-19 | $161.65 | $2.3M | -4.6% | -10.0% | -15.3% |
| ABBV | SELL | 2023-04-03 | 2023-04-05 | $160.03 | $4.8M | -0.8% | -7.9% | -14.4% |
| ABBV | SELL | 2023-03-01 | 2023-03-02 | $155.00 | $2.3M | -0.3% | +3.9% | -10.6% |
| ABBV | SELL | 2023-02-21 | 2023-02-21 | $151.04 | $4.6M | +3.4% | +2.8% | -4.0% |
| ABBV | SELL | 2022-03-01 | 2022-03-01 | $148.24 | $1.8M | +0.9% | +9.8% | -0.2% |
| ABBV | SELL | 2021-12-13 | 2021-12-14 | $125.85 | $813K | +4.8% | +4.1% | +18.6% |
| ABBV | SELL | 2021-08-23 | 2021-08-25 | $120.00 | $1.6M | -9.8% | -11.4% | -1.6% |
| ABBV | SELL | 2021-03-01 | 2021-03-02 | $108.61 | $1.8M | +1.3% | +1.6% | +5.0% |
| ABBV | SELL | 2021-02-22 | 2021-02-24 | $104.71 | $4.2M | -2.2% | -2.3% | +5.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.